Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.
about
Progress toward overcoming hypoxia-induced resistance to solid tumor therapyDifferential Impacts of Alternative Splicing Networks on ApoptosisRole of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.A new mouse avatar model of non-small cell lung cancer.YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB networkThe vacuolar H+ ATPase is a novel therapeutic target for glioblastoma.Survivin contributes to DNA repair by homologous recombination in breast cancer cells.Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival.Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1.Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells.Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.Epigenetic effects of chromatin remodeling agents on organotypic cultures.Growth inhibition and chemo-radiosensitization of esophageal squamous cell carcinoma by survivin-shRNA lentivirus transfectionSurvivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine
P2860
Q26796405-FD1912F6-0ADE-424B-B65D-46D39C360E1DQ28078238-124E73B7-18B1-4131-985E-ADB60CC85A7AQ34501989-79BDBBCD-EB0F-46D4-A345-73B2A3C19615Q35141122-0C689C97-37E8-407F-BB5B-7211C68835F7Q35955360-7C2BFD31-35F1-4540-A9F9-7D0A6D8021A9Q36232092-714B41BD-2BFE-4D24-8FFB-92DFD218E5D3Q36441625-3549AFCD-5F56-4156-B8E4-0250D290F346Q37552296-65EA400B-32EE-411C-ADE5-DF0E170B75BFQ37681199-57FE8393-A782-47A6-B3EB-648AF31A9676Q38839786-4E976AF6-58D8-40CB-BDFC-A8C39E9A982CQ38851282-DF5D5E49-279C-4ED8-9B03-EC3AA157E2F0Q38853955-23320518-5C24-4367-9C5C-76CE1189C9C8Q38855662-A4AD5019-6910-473E-84DC-188087F7B2C9Q41489534-972EE175-1FDC-46CB-AB99-FA3CB19AE61AQ41661254-74400001-9183-473B-A3DF-1ACADE2822A9Q48371625-DFDE61E9-4542-4A9B-AC2D-B1EA4DFD502FQ52881834-D2BC4109-22EC-45A8-9F68-F1B83F1D4933Q58794874-79016647-50C7-4276-8563-1F2A28374DB2Q58796644-49139A7B-80A5-4B91-8F0B-4B3526688909
P2860
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Survivin family proteins as no ...... ganotypic human breast tumors.
@ast
Survivin family proteins as no ...... ganotypic human breast tumors.
@en
type
label
Survivin family proteins as no ...... ganotypic human breast tumors.
@ast
Survivin family proteins as no ...... ganotypic human breast tumors.
@en
prefLabel
Survivin family proteins as no ...... ganotypic human breast tumors.
@ast
Survivin family proteins as no ...... ganotypic human breast tumors.
@en
P2093
P2860
P50
P356
P1476
Survivin family proteins as no ...... rganotypic human breast tumors
@en
P2093
Alessia Lopergolo
Dario C Altieri
David C Schultz
Dayana Rivadeneira
Giacomina P Moro
P2860
P2888
P356
10.1186/BCR3666
P577
2014-05-30T00:00:00Z
P5875
P6179
1006857662